Anime fans looked back on 2024 and picked the best anime girl of the year overall! Do you agree with their pick?

Shonen Jump's hottest manga Ichi the Witch is new addition to the magazine but fans already got a glimpse of the characters ...

Avatar: The Last Airbender and its sequel series The Legend of Korra are both colored by their wonderful minor characters.

The Mahabharat is one of the two major epics in Sanskrit of ancient India It contains over one lakh couplets and is thrice as long as the Bible However only a fraction of the narration actually deals ...

Here we talk about the best (and worst) heroes in the game. If you are a new or returning player, our Anime Crossover Defense tier list will give you a good understanding of the current metagame so ...

Here is a look at different reasons why your knee may hurt when bending your leg or sitting. Osteoarthritis—the more common type of knee arthritis—occurs when the joint structures break down. Commonly ...

The captivating story of Oshi no Ko doesn’t end with the anime. This unique seinen series, created by Aka Akasaka and illustrated by Mengo Yokoyari, blends the world of idol stardom with the mystery ...

"He can sit there and think about that play over and over, but I've gotta be better for him. That’s what it comes down to, and get him more involved." Here's the play in question. Thanks to a ...

Safer just to sit on all the money lest an irate chief executive ... We’ve seen partisan warfare in which Congress shut down the government. This is something new: a president shutting down ...

are sitting in playoff spots for the District 3 tournament with less than two weeks to play in the regular season. The BCIAA tournament for the girls will start on Saturday, Feb. 8 with the finals ...

Activist short-seller firm Hindenburg Research is calling it quits after an impactful eight-year run in which its reports took on high-profile investors like Carl Icahn and Gautam Adani and helped ...

This newer formulation will almost certainly have to deal with the challenges from ivonescimab and PM8002 down the road. However, Merck is working on other products. It recently signed an ...